Cue Biopharma, Inc.
Public company- Headquarters
- SOMERVILLE, Massachusetts
- Ticker
- CUE
- CIK
- 0001645460
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 3, 2026
Executive appointmentCFO appointed: James Ahlers
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOJames Ahlers | Aug 3, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive appointment
CFO appointed: James Ahlers
James Ahlers was named Chief Financial Officer of Cue Biopharma, Inc., effective July 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 3, 2026Role: Chief Financial Officer
Only one public record so far. We add events as soon as a new filing lands; watch Cue Biopharma, Inc. to get them in your digest.
Last verified Nov 8, 2026